Hyris and Signlabs will partner together to commercialize Hyris signature technology, Hyris System™, and Hyris testing solutions in Singapore.

Hyris and P.Intertrade Equipments will partner together to commercialize Hyris signature technology, Hyris System, and Hyris testing solutions in Thailand.

From October 5th to October 7th, Hyris will be present at the SIBioC 2022 in Genova, to present Hyris marketplace approach and Hyris System^TM disruptive featuresfor laboratory medicine.

Our team will discuss with partners and prospects at Hyris stand First Floor, bar area.

From September 22nd to September 24th, Hyris will be present at the SEI 2022 in Leon, to show the scientific approach related to our new T Cells test to monitor the cellular immunity to SARS-CoV-2.

On September 22nd at 1pm our Product Specialist Matteo Audano will hold a talk at the dedicated symposium titled "Development of a PCR diagnostic test to monitor the viral cellular immunity".

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, our much-anticipated T-Cell Test based on innovative qPCR technology is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™.

Hyris presented its Hyris System™ and the new T Cells test in Munich last week, at Analytica 2022, the world largest laboratory technology fair.